MR. YUSUF QAMRUZZAMAN (MD) – Hematology & Oncology Physician, NPI 1174738231
Hematology & Oncology Physician
Main info
Doctor Profile
Profile Insights
NPPES metrics only — not quality of care.
476 HEMATOLOGY/ONCOLOGY in MI
Provider Addresses for MR. YUSUF QAMRUZZAMAN (MD)
3577 W. 13 MILE ROAD STE 103
ROYAL OAK, MI 48073
Phone: (248) 288-4500
Fax: (248) 288-0450
Type: Mailing
3577 W 13 MILE ROAD STE 103
ROYAL OAK, MI 48073
Phone: (313) 274-1800
Fax: (313) 769-6285
Type: Location
861, Monroe Street, Dearborn, Wayne County, Michigan, 48124, United States
DEARBORN, MI 481242308
Phone:
Type: Mailing
NPPES updates history
No NPPES updates recorded for this provider.
Prescription Activity
Loading prescription activity...
Open Payments (CMS)
CMS reports 93 Open Payments records for all available years, with a total value of $1,718.
Total Amount is formed as General ($1,718) + Research ($0) + Ownership ($0) = $1,718.
Last reported payment date: 2024-12-30 • Largest payer in this snapshot: Novartis Pharmaceuticals Corporation ($239).
Total Amount
$1,718
General + Research + Ownership
Payments
93
Total payment records
General Amount
$1,718
General payments
Research Amount
$0
Research funding
Ownership Amount
$0
Ownership interests
Ownership Count
0
Ownership records
Last Payment Date
2024-12-30
Latest reported date
Top Companies
Largest payers in this snapshot
| Company | Amount |
|---|---|
| Novartis Pharmaceuticals Corporation | $239 |
| Janssen Biotech, Inc. | $128 |
| Genentech USA, Inc. | $66 |
| Daiichi Sankyo Inc. | $66 |
| Seagen Inc. | $54 |
Medicare Enrollment & Revalidation
Source: CMS public data · Not endorsed by CMS ·
Educational use only—not medical, billing, or legal advice.
PECOS enrollment status
Participating (accepts Medicare assignment)
Enrollment effective: 2013-12-17
PECOS data refreshed: 2026-05-27
Medicare revalidation (CMS due date list)
Due date not assigned yet
CMS is tracking this Medicare enrollment for revalidation, but has not published a due date.
Enrollment records
1
Earliest due date
Not assigned (TBD)
CMS data updated
2026-06-01
Revalidation progress
- Medicare enrolled
- On CMS revalidation list
- Due date assigned
- Revalidate in PECOS
CMS enrollment records
| Enrollment ID | Type | Specialty | State | Due date |
|---|---|---|---|---|
| I20131217000110 | I | Hematology/Oncology | MI | TBD |
What to do next
- No action required while the due date shows TBD.
- Check the CMS Revalidation Lookup Tool periodically — CMS updates the list about every 60 days.
- Do not submit a revalidation application in PECOS until CMS publishes a concrete due date.
Prepare CMS-855 application → · Look up this NPI in PECOS → · Verify on CMS PECOS
Medicare Utilization (FFS)
Source: CMS public data · Not endorsed by CMS · Beneficiary counts under 11 are suppressed in source data ·
Educational use only—not medical, billing, or legal advice.
Top Medicare procedures (2023) · refreshed 2026-05-27
| HCPCS | Description | Services | Beneficiaries | Medicare allowed |
|---|---|---|---|---|
| Q5110 | Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram | 17,880 | 22 | $0 |
| Q0138 | Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 12,750 | 21 | $0 |
| J9264 | Injection, paclitaxel protein-bound particles, 1 mg | 5,500 | 12 | $0 |
| J1453 | Injection, fosaprepitant, 1 mg | 4,200 | 13 | $0 |
| J0897 | Injection, denosumab, 1 mg | 3,840 | 18 | $0 |
Insurance plans in this area (ZIP 48073)
Loading plans...
Group practice members
- 1
- 2
- 3
- 4
| Name | Specialty | State |
|---|---|---|
| Cardiovascular Disease (Cardiology) | MI | |
| - | MI | |
| - | MI | |
| - | MI | |
| Internal Medicine | MI | |
| Otolaryngology, Plastic And Reconstructive Surgery | MI | |
| Medical Oncology, Internal Medicine | MI | |
| - | MI | |
| - | AE | |
| Pediatric Medicine | MI |
Reviews
All reviews are moderated before publication. Reviews reflect users' opinions; we do not verify the accuracy of individual reviews.
No reviews yet. Be the first to share your experience — your opinion helps families compare providers.